Syndax Pharmaceuticals Inc (SNDX)
Cash & Equivalents
$336.48M
Quarterly · Period ending: · USD
SNDX Cash & Equivalents
Latest reported$336.48Mperiod ending
Latest reported$336.48Mperiod ending
SNDX Quarterly Cash & Equivalents ($537.00 → $336.48M)
Quarterly Cash & Equivalents
High-resolution chart · PNG
SNDX cash & equivalents history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cash & Equivalents (USD) |
|---|---|
| 336,477,000 | |
| 130,893,000 | |
| 134,930,000 | |
| 116,808,000 | |
| 108,636,000 | |
| 153,993,000 | |
| 154,083,000 | |
| 133,019,000 | |
| 105,396,000 | |
| 114,615,000 | |
| 295,394,000 | |
| 94,550,000 | |
| 97,275,000 | |
| 57,517,000 | |
| 74,356,000 | |
| 71,377,000 | |
| 120,239,000 | |
| 188,773,000 | |
| 221,965,000 | |
| 71,433,000 | |
| 68,041,000 | |
| 64,386,000 | |
| 115,243,000 | |
| 56,356,000 | |
| 53,611,000 | |
| 44,629,000 | |
| 24,609,000 | |
| 30,581,000 | |
| 26,666,000 | |
| 58,116,000 | |
| 33,769,000 | |
| 26,705,000 | |
| 32,204,000 | |
| 27,981,000 | |
| 35,168,000 | |
| 20,732,000 | |
| 22,988,000 | |
| 22,356,000 | |
| 23,844,000 | |
| 12,753,000 | |
| 14,441,000 | |
| 23,187,000 | |
| 23,179,000 | |
| 54,214,000 | |
| -12,208,000 | |
| 10,009,000 | |
| 11,589,000 | |
| 4,680,000 | |
| 6,840,000 | |
| 10,104,000 | |
| 5,037,000 | |
| -628 | |
| 537 |